Patrick D. Kirwin Form 3 ProMIS Neurosciences / Patrick D. Kirwin ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Kirwin Patrick D.

(Last) (First) (Middle)

C/O PROMIS NEUROSCIENCES INC.,

1920 YONGE STREET, SUITE 200

(Street)

TORONTO A6 M4S 3E2

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/07/2022

3. Issuer Name and Ticker or Trading Symbol
ProMIS Neurosciences Inc. [ PMN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	37,983	D
Common Shares	22,332	I	By Patrick D. Kirwin Professional Corp
Common Shares	2,383	I	By Patrick Kirwin TFSA
Common Shares	5,732	I	By his spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	(2)	10/07/2025	Common Shares	4,167	4.8(1)	D
Option (right to buy)	(3)	09/19/2026	Common Shares	4,167	9.6(1)	D
Option (right to buy)	(4)	03/30/2021	Common Shares	8,333	10.2(1)	D
Warrants (right to buy)	08/09/2017	08/09/2022	Common Shares	667	18(1)	I	By his spouse
Warrants (right to buy)	03/05/2021	03/05/2026	Common Shares	3,333	12(1)	D

Explanation of Responses:

1. Conversion or exercise price is in Canadian dollars.

2. The option agreement provides that 25% of the options vest immediately, with the remainder vesting ratably over the next three quarters. The option was granted on October 7, 2015.

3. The option agreement provides that 25% of the options vest immediately, with the remainder vesting ratably over the next three quarters. The option was granted on September 19, 2016.

4. The option agreement provides that 25% of the options vest immediately, with the remainder vesting ratably over the next three quarters. The option was granted on March 30, 2021.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Jason L. Langford, Attorney-in-Fact for Patrick D. Kirwin	07/07/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.